期刊文献+

mTOR对非激素依赖性前列腺癌的作用研究 被引量:2

Study on the Effect of mTOR on Androgen-independent Prostate Cancer
原文传递
导出
摘要 [目的]探讨mTOR对非激素依赖性前列腺癌裸鼠移植瘤的影响及作用机制。[方法]背部皮下注射LNCaP细胞复制裸鼠前列腺癌模型,去势同时瘤体内注射mTOR shRNA慢病毒颗粒,记录移植瘤进入激素耐药的时间,同时测量肿瘤组织体积及重量;RT-PCR和Western blot方法分别检测肿瘤组织中mTOR、CgA、NSE的mRNA和蛋白表达情况;采用PI染色和AV/PI染色联合流式细胞术检测肿瘤组织中细胞周期变化和细胞凋亡情况。[结果]与对照组相比,瘤体内注射mTOR shRNA慢病毒颗粒后,移植瘤进入激素耐药时间有所延长,肿瘤组织的体积和重量均显著下降(P<0.05),细胞周期中S期细胞所占比例减少、凋亡细胞有所增加,同时,CgA和NSE表达下降(P<0.05)。[结论]瘤体内注射mTOR shRNA慢病毒颗粒可抑制前列腺癌神经内分泌分化,促进移植瘤组织凋亡、抑制细胞增殖。 [Purpose] To investigate the effect of mTOR on androgen-independent prostate cancer and its mechanisms.[Methods] Subcutaneous xenotransplantation tumor model was established by injection of LNCaP cells into the back of nude mice.The nude mice was castrated and injected with mTOR shRNA lentivirus particles,then tumor volumes and weights were measured.RT-PCR and Western blot were used to detect the expressions of mTOR,CgA and NSE mRNA and proteins respectively.The effects of mTOR shRNA on the cell cycle and apoptosis of tumor cells were examined by PI and AV/PI staining combined with flow cytometry.[Results] Compared with the control group,the duration of androgen resistance in mTOR shRNA group was longer and tumor weight and volume were decreased(P0.05).The ratio of cells in S phase released and the ratio of apoptosis cells increased.Meanwhile,the expression of CgA and NSE were obviously decreased.[Conclusion] Intratumor injection with mTOR shRNA lentivirus particles could inhibit the neuroendocrine differentiaton in prostate cancer,stimulate tumor cells apoptosis and inhibit proliferation.
出处 《肿瘤学杂志》 CAS 2013年第12期947-953,共7页 Journal of Chinese Oncology
基金 辽宁省博士启动基金(20101060)
关键词 肿瘤 非激素依赖性 前列腺肿瘤 MTOR 移植瘤 神经内分泌分化 neoplasms hormone-independent prostate neoplasms mTOR xenotransplanted tumors neuroendocrine differentiation
  • 相关文献

参考文献21

二级参考文献122

共引文献255

同被引文献15

  • 1KASPER JS, GIOVANNUCCI E. A meta-analysis of diabetes mellitus and the risk of prostate cancer [J]. Cancer Epidemiol Bi- omarkers Prey,2006, 5(11): 2056-2062.
  • 2BARTL J, SCHOLZ CJ, HINTERBERGER M, et al. Disorder- specific effects of polymorphisms at opposing ends of the insulin degrading enzyme gene [J]. BMC Med Genet, 2011,12 (1) : 1-8.
  • 3BARTL J, SCHOLZ CJ, HINTERBERGER M, et al. Disorder- specific effects of polymorphisms at opposing ends of the Insulin Degrading Enzyme gene [J]. BMC Med Genet, 2011, 22 (12) : 151.
  • 4CANNATA D, FIERZ Y, VIJAYAKUMAR A. Type 2 diabetes and cancer: what is the connection? [J]. Mt Sinai J Med, 2010, 77(2) : 197-213.
  • 5BONOVAS S, PEPONIS V, FILIOUSSI K. Diabetes mellitus as a risk factor for primary open-angle glaucoma: a meta-analysis [J]. Diabet Med, 2004, 21(6): 609-614.
  • 6REAVEN GM. Banting lecture 1988. Role of insulin resistance in human disease [J]. Diabetes,1988, 37(12): 1595-607.
  • 7GROSSMANN M, THOMAS MC, PANAGIOTOPOULOS S, et al. Low testosterone levels are common and associated with in- sulin resistance in men with diabetes [ J]. J Clin Endocrinol Metab, 2008, 93(5): 1834-1840.
  • 8KWAK SH, CHO YM, MOON MK, et al. Association of poly- morphisms in the insulin degrading enzyme gene with type 2 dia- betes in the Korean population [J]. Diabetes Res Clin Pratt, 2008, 79(2) : 284-290.
  • 9GROVES CJ, WILTSHIRE S, SMEDLEY D, et al. Association and haplotype analysis of the insulin-degrading enzyme (IDE) gene, a strong positional and biological candidate for type 2 dia- betes susceptibility [J]. Diabetes, 2003, 52(5) : 1300-1305.
  • 10GU HF, EFENDIC S, NORDMAN S, et al. Quantitative trait loci near the insulin-degrading enzyme (IDE)gene contribute to variation in plasma insulin levels [J]. Diabetes, 2004, 53 (8): 2137-2142.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部